Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new revision entry (v3.4.2) to the record history and removed the funding-status notice along with the earlier Revision: v3.4.1 entry.SummaryDifference0.9%

- Check20 days agoChange DetectedNotice about government funding status is now displayed at the top of the page and the revision indicator updated to v3.4.1 (replacing v3.4.0); these are UI/metadata changes and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe Record History view now includes a glossary option, color-coded additions and deletions, and explicit version labels to show how study record changes are presented.SummaryDifference1%

- Check42 days agoChange DetectedThe study record versions now include a new revision entry v3.3.4 and remove v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page history now shows a new revision label 'Revision: v3.3.3', and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' appear to be removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRecord History now lists an added Revision: v3.3.2 and a removed Revision: v3.2.0. These are maintenance entries to the history log rather than changes to study records.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.